| Clopidogrel Taw Pharma 75 mg film-coated tablets EU/1/09/559/001-016 |
Clopidogrel hydrochloride |
Taw Pharma (Ireland) Limited |
— |
| Clopidogrel Teva 75 mg film-coated tablets EU/1/09/540/1-16 |
Clopidogrel hydrogensulfate |
Teva B.V. |
— |
| Clopidogrel Viatris 75 mg film-coated tablets EU/1/09/568/001-020 |
Clopidogrel besilate |
Viatris Limited |
— |
| Clopidogrel Zentiva 300 mg film-coated tablets EU/1/08/465/15-17 |
Clopidogrel |
Zentiva k.s. |
— |
| Clopidogrel/Acetylsalicylic acid Viatris 75 mg/100 mg film-coated tablets EU/1/19/1395/006-010 |
Clopidogrel hydrogensulfate, Acetylsalicylic acid |
Mylan Pharmaceuticals Limited |
— |
| Clopidogrel/Acetylsalicylic acid Viatris 75 mg/75 mg film-coated tablets EU/1/19/1395/001-005 |
Clopidogrel hydrogensulfate, Acetylsalicylic acid |
Mylan Pharmaceuticals Limited |
— |
| Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/100 mg film-coated tablets EU/1/10/623/8-14 |
Acetylsalicylic acid, Clopidogrel hydrogensulfate |
Sanofi-Aventis Groupe |
— |
| Clopidogrel/Acetylsalicylic acid Zentiva 75 mg/75 mg film-coated tablets EU/1/10/623/1-7 |
Acetylsalicylic acid, Clopidogrel hydrogensulfate |
Sanofi-Aventis Groupe |
— |
| Co-amoxiclav 1000mg/200mg powder for solution for injection/infusion PA2059/026/001 |
Amoxicillin, Clavulanic acid |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Co-amoxiclav Bluefish 500 mg/125 mg film- coated tablets PA1436/002/002 |
Clavulanic acid, Amoxicillin trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Co-amoxiclav Bluefish 875 mg/125 mg film- coated tablets PA1436/002/003 |
Clavulanic acid, Amoxicillin trihydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Co-codamol 15 mg/500 mg film-coated tablets PA22871/020/001 |
Paracetamol, Codeine phosphate hemihydrate |
Azure Pharmaceuticals Ltd. |
Marketed |
| Coagadex 250 IU powder and solvent for solution for injection EU/1/16/1087/001 |
Human coagulation factor x |
Kedrion S.p.A. |
— |
| Coagadex 500 IU powder and solvent for solution for injection EU/1/16/1087/002 |
Human coagulation factor x |
Kedrion S.p.A. |
— |
| CoAprovel 150 mg/12.5 mg film-coated tablets EU/1/98/086/011-015 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 150 mg/12.5 mg tablets EU/1/98/086/001-003 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 300 mg/12.5 mg film-coated tablets EU/1/98/086/016-020 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 300 mg/12.5 mg tablets EU/1/98/086/004-006 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| CoAprovel 300 mg/25 mg film-coated tablets EU/1/98/086/023-028 |
Irbesartan, Hydrochlorothiazide |
Sanofi Pharma Bristol-Myers Squibb SNC |
— |
| Cocois Ointment, coal tar 12.0% sulphur for external use 4.0%, salicylic acid 2.0% PA1638/005/001 |
Coal tar solution, Sulphur for external use, Salicylic acid |
RPH Pharmaceuticals AB |
Marketed |
| Codant 30 mg Tablets PA0073/029/001 |
Codeine phosphate hemihydrate |
Mercury Pharmaceuticals (Ireland) Ltd |
Not marketed |
| Colchicine 500 microgram Tablets PA22865/002/001 |
Colchicine |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Colchicine Tiofarma 1000 microgram tablets PA2200/001/002 |
COLCHICINE PH. EUR. |
Tiofarma B.V. |
Not marketed |
| Colchicine Tiofarma 500 microgram tablets PA2200/001/001 |
COLCHICINE PH. EUR. |
Tiofarma B.V. |
Marketed |
| Colica Colic Granules HOA1149/001/001 |
CITRULLUS COLOCYNTHIS 30C HAP/PH.EUR, Dioscorea villosa |
A. Nelson & Company Limited |
Not marketed |
| Colobreathe 1,662,500 IU inhalation powder, hard capsules EU/1/11/747/001 |
Colistimethate sodium |
Essential Pharma Limited |
— |
| Columvi 10 mg concentrate for solution for infusion EU/1/23/1742/002 |
Glofitamab |
Roche Registration GmbH |
— |
| Columvi 2.5 mg concentrate for solution for infusion EU/1/23/1742/001 |
Glofitamab |
Roche Registration GmbH |
— |
| Combivir 150 mg/300 mg film-coated tablets EU/1/98/058/001 |
Zidovudine, Lamivudine |
ViiV Healthcare BV |
— |
| Combivir 150 mg/300 mg film-coated tablets EU/1/98/058/002 |
Zidovudine, Lamivudine |
ViiV Healthcare BV |
— |
| Combodart 0.5 mg/ 0.4 mg hard capsules PPA23080/025/001 |
Dutasteride, Tamsulosin hydrochloride |
Merit Pharmaceuticals Limited |
— |
| COMETRIQ 20 mg hard capsules EU/1/13/890/001 |
Cabozantinib (s)-malate |
Ipsen Pharma |
— |
| COMETRIQ 80 mg hard capsules EU/1/13/890/002-003 |
Cabozantinib (s)-malate |
Ipsen Pharma |
— |
| Comirnaty EU/1/20/1528/001 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/002-003 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/004-005 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/010 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty EU/1/20/1528/028-031 |
Tozinameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 years EU/1/20/1528/034 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/032-033 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/035 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY JN.1 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/036 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| Comirnaty JN.1 30 micrograms/dose dispersion for injection EU/1/20/1528/028-29 |
Bretovameran |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY KP.2 10 micrograms/dose dispersion for injection children 5 to 11 years EU/1/20/1528/040-041 |
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY KP.2 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years EU/1/20/1528/042 |
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY KP.2 30 micrograms/dose dispersion for injection adults and adolescents from 12 year EU/1/20/1528/037-038 |
COVID-19 mRNA vaccine (nucleoside-modified) |
BioNTech Manufacturing GmbH |
— |
| Comirnaty LP.8.1 10 micrograms/dose dispersion for injection EU/1/20/1528/048-049 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| COMIRNATY LP.8.1 30 micrograms/dose dispersion for injection EU/1/20/1528/045-046 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| Comirnaty LP.8.1 30 micrograms/dose dispersion for injection in pre-filled syringe EU/1/20/1528/051 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |
| Comirnaty LP8.1 30 micrograms/dose dispersion for injection in pre-filled syringe EU/1/20/1528/047 |
Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation |
BioNTech Manufacturing GmbH |
— |